Go Pro
→ The ultimate IPO unicorn before Labor Day (From Weiss Ratings) (Ad)tc pixel Free PARK Stock Alerts

Park Dental Partners (PARK) Competitors

$20.43 -0.06 (-0.29%)
As of 04:00 PM Eastern
Compare

PARK vs. VMD, TACO, BDSX, INFU, and XGN

Should you buy Park Dental Partners stock or one of its competitors? Park Dental Partners's main competitors and comparable companies include Viemed Healthcare (VMD), Berto Acquisition (TACO), Biodesix (BDSX), InfuSystem (INFU), and Exagen (XGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Park Dental Partners compare to Viemed Healthcare?

Park Dental Partners (NASDAQ:PARK) and Viemed Healthcare (NASDAQ:VMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

74.2% of Viemed Healthcare shares are owned by institutional investors. 10.6% of Park Dental Partners shares are owned by insiders. Comparatively, 20.6% of Viemed Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Viemed Healthcare had 4 more articles in the media than Park Dental Partners. MarketBeat recorded 4 mentions for Viemed Healthcare and 0 mentions for Park Dental Partners. Viemed Healthcare's average media sentiment score of 1.63 beat Park Dental Partners' score of 0.00 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company Overall Sentiment
Park Dental Partners Neutral
Viemed Healthcare Very Positive

Viemed Healthcare has higher revenue and earnings than Park Dental Partners. Park Dental Partners is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.40-$360K$1.0519.46
Viemed Healthcare$270.28M1.28$14.93M$0.3625.22

Viemed Healthcare has a net margin of 4.81% compared to Park Dental Partners' net margin of 0.00%. Viemed Healthcare's return on equity of 10.16% beat Park Dental Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
Viemed Healthcare 4.81%10.16%7.22%

Park Dental Partners presently has a consensus target price of $28.50, suggesting a potential upside of 39.50%. Viemed Healthcare has a consensus target price of $14.00, suggesting a potential upside of 54.19%. Given Viemed Healthcare's higher probable upside, analysts plainly believe Viemed Healthcare is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Viemed Healthcare
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25

Summary

Viemed Healthcare beats Park Dental Partners on 11 of the 14 factors compared between the two stocks.

How does Park Dental Partners compare to Berto Acquisition?

Berto Acquisition (NASDAQ:TACO) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

In the previous week, Berto Acquisition's average media sentiment score of 1.95 beat Park Dental Partners' score of 0.00 indicating that Berto Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
Berto Acquisition Very Positive
Park Dental Partners Neutral

Company Net Margins Return on Equity Return on Assets
Berto AcquisitionN/A N/A N/A
Park Dental Partners N/A N/A N/A

Park Dental Partners has a consensus target price of $28.50, indicating a potential upside of 39.50%. Given Park Dental Partners' stronger consensus rating and higher possible upside, analysts clearly believe Park Dental Partners is more favorable than Berto Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Berto Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

Berto Acquisition has higher earnings, but lower revenue than Park Dental Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Berto AcquisitionN/AN/AN/AN/AN/A
Park Dental Partners$244.49M0.40-$360K$1.0519.46

Summary

Park Dental Partners beats Berto Acquisition on 5 of the 6 factors compared between the two stocks.

How does Park Dental Partners compare to Biodesix?

Park Dental Partners (NASDAQ:PARK) and Biodesix (NASDAQ:BDSX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

In the previous week, Biodesix had 1 more articles in the media than Park Dental Partners. MarketBeat recorded 1 mentions for Biodesix and 0 mentions for Park Dental Partners. Biodesix's average media sentiment score of 0.67 beat Park Dental Partners' score of 0.00 indicating that Biodesix is being referred to more favorably in the news media.

Company Overall Sentiment
Park Dental Partners Neutral
Biodesix Positive

Park Dental Partners has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.40-$360K$1.0519.46
Biodesix$88.50M3.12-$35.26M-$3.17N/A

Park Dental Partners has a net margin of 0.00% compared to Biodesix's net margin of -26.97%. Park Dental Partners' return on equity of 0.00% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
Biodesix -26.97%-788.19%-30.33%

21.0% of Biodesix shares are held by institutional investors. 10.6% of Park Dental Partners shares are held by company insiders. Comparatively, 23.2% of Biodesix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Park Dental Partners currently has a consensus price target of $28.50, indicating a potential upside of 39.50%. Biodesix has a consensus price target of $31.33, indicating a potential upside of 19.68%. Given Park Dental Partners' higher possible upside, research analysts plainly believe Park Dental Partners is more favorable than Biodesix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Biodesix
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.80

Summary

Park Dental Partners and Biodesix tied by winning 7 of the 14 factors compared between the two stocks.

How does Park Dental Partners compare to InfuSystem?

Park Dental Partners (NASDAQ:PARK) and InfuSystem (NYSE:INFU) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment.

InfuSystem has a net margin of 1.12% compared to Park Dental Partners' net margin of 0.00%. InfuSystem's return on equity of 2.78% beat Park Dental Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
InfuSystem 1.12%2.78%1.41%

InfuSystem has lower revenue, but higher earnings than Park Dental Partners. Park Dental Partners is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.40-$360K$1.0519.46
InfuSystem$143.34M1.72$870K$0.4129.85

In the previous week, InfuSystem had 4 more articles in the media than Park Dental Partners. MarketBeat recorded 4 mentions for InfuSystem and 0 mentions for Park Dental Partners. InfuSystem's average media sentiment score of 1.51 beat Park Dental Partners' score of 0.00 indicating that InfuSystem is being referred to more favorably in the news media.

Company Overall Sentiment
Park Dental Partners Neutral
InfuSystem Very Positive

71.1% of InfuSystem shares are owned by institutional investors. 10.6% of Park Dental Partners shares are owned by insiders. Comparatively, 10.8% of InfuSystem shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Park Dental Partners presently has a consensus target price of $28.50, suggesting a potential upside of 39.50%. InfuSystem has a consensus target price of $16.67, suggesting a potential upside of 36.17%. Given Park Dental Partners' higher probable upside, analysts plainly believe Park Dental Partners is more favorable than InfuSystem.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
InfuSystem
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Summary

InfuSystem beats Park Dental Partners on 11 of the 15 factors compared between the two stocks.

How does Park Dental Partners compare to Exagen?

Park Dental Partners (NASDAQ:PARK) and Exagen (NASDAQ:XGN) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

Park Dental Partners has a net margin of 0.00% compared to Exagen's net margin of -26.61%. Park Dental Partners' return on equity of 0.00% beat Exagen's return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
Exagen -26.61%-104.46%-28.93%

75.3% of Exagen shares are held by institutional investors. 10.6% of Park Dental Partners shares are held by company insiders. Comparatively, 10.4% of Exagen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Park Dental Partners currently has a consensus price target of $28.50, suggesting a potential upside of 39.50%. Exagen has a consensus price target of $9.63, suggesting a potential upside of 26.98%. Given Park Dental Partners' higher probable upside, equities research analysts plainly believe Park Dental Partners is more favorable than Exagen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Exagen
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.89

Park Dental Partners has higher revenue and earnings than Exagen. Exagen is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.40-$360K$1.0519.46
Exagen$66.57M2.76-$19.95M-$0.81N/A

In the previous week, Exagen had 2 more articles in the media than Park Dental Partners. MarketBeat recorded 2 mentions for Exagen and 0 mentions for Park Dental Partners. Exagen's average media sentiment score of 1.79 beat Park Dental Partners' score of 0.00 indicating that Exagen is being referred to more favorably in the news media.

Company Overall Sentiment
Park Dental Partners Neutral
Exagen Very Positive

Summary

Park Dental Partners beats Exagen on 8 of the 14 factors compared between the two stocks.

Get Park Dental Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for PARK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PARK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PARK vs. The Competition

Export
MetricPark Dental PartnersHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$97.44M$10.00B$7.17B$12.88B
Dividend YieldN/A2.56%2.53%8.57%
P/E RatioN/A34.59272.9925.40
Price / Sales0.404.93612.7397.00
Price / Cash4.67120.9077.8252.27
Price / Book3.263.9912.856.17
Net Income-$360K$313.25M$3.47B$349.50M
7 Day Performance-2.01%1.03%1.24%-0.05%
1 Month Performance10.43%0.29%5.81%0.80%
1 Year PerformanceN/A15.42%25.75%15.62%

Park Dental Partners Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PARK
Park Dental Partners
2.7084 of 5 stars		$20.43
-0.3%		$28.50
+39.5%		N/A$97.44M$244.49MN/A1,212
VMD
Viemed Healthcare
4.6809 of 5 stars		$9.11
+0.2%		$14.00
+53.8%		+32.5%$346.43M$270.28M25.261,382
TACO
Berto Acquisition
0.9885 of 5 stars		$10.47
0.0%		N/A+2.1%$341.37MN/AN/A7,892
BDSX
Biodesix
3.8112 of 5 stars		$29.82
+17.5%		$31.33
+5.1%		+213.7%$313.12M$88.50MN/A220
INFU
InfuSystem
3.9432 of 5 stars		$12.05
+0.8%		$16.67
+38.4%		+15.5%$243.60M$143.34M201.20410

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:PARK) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Before Anthropic becomes impossible to ignore...
Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...
The Oxford Club | Sponsoredtc pixel
They're not buying gold. They're buying this.
Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...
Behind the Markets | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
Wall Street pays $32K for this type of stock market data. (But see this Labor Day deal now!)
The Bloomberg Terminal costs $32,000 a year and sits on the desks of more than 350,000 Wall Street traders. Mo...
Weiss Ratings | Sponsoredtc pixel
This Overlooked Fund Turns AI Stocks Into Weekly Income
A small fund pays investors weekly income from AI stocks that don't pay dividends on their own. Chief Incom...
Investors Alley | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...
Eagle Publishing | Sponsoredtc pixel